Why is Fischer Medical falling/rising?

As of 28-Aug, Fischer Medical Ventures Ltd is experiencing a decline in its stock price, currently at 1,045.40, reflecting a decrease of 19.0 points or 1.79%. The stock has been losing value for the past two days, with a total drop of 2.66% during this period. It is currently 3.79% away from its 52-week high of Rs 1085. Despite a strong performance over the past year, with a return of 70.82%, the company has shown signs of poor management efficiency, indicated by a low return on equity (ROE) of 1.39% and a significant drop in profits by 20% over the past year. Additionally, the stock's valuation appears expensive with a price-to-book value of 22.1, which may deter investors.
In the broader market context, Fischer Medical's short-term performance has been relatively better than the benchmark, with a 1-week return of -0.22% compared to the Sensex's -2.34%. However, the stock's recent decline may be influenced by falling investor participation, as evidenced by a decrease in delivery volume. While the company has demonstrated impressive growth in net sales and operating profit, the lack of domestic mutual fund investment could indicate a lack of confidence in the stock's current valuation. Overall, these factors contribute to the stock's recent downward movement despite its historical performance.